Concepedia

Author

Otto Prümmer

Universität Ulm

Also Known As

E Schäfer, M. Bentz, O Prummer, O Prümmer, O. PRÜMMER, O. Prummer, O. Prümmer, OTTO PRÜMMER, Otto Prummer, Otto Prümmer

51

Publications

1.4K

Citations

20

H-Index

63

Concepts

All Affiliations

Universität UlmHeidelberg UniversityUniversity Hospital UlmPraxis für Hämatologie und OnkologieLudwig-Maximilians-Universität München
OP

About

Otto Prümmer is an author at Universität Ulm specializing in medicine, immunology, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

16

641

2

Cell Biology

7

7

167

3

Health Sciences

6

6

98

4

Allergy

2

2

30

5

Biomedical Engineering

1

1

13

Otto Prümmer

×

29

Publications

1.1K

Citations

18

H-Index

YearCitations

Quantification of the initial decline of serum hepatitis c virus RNA and response to interferon alfa

Stefan Zeuzem, Jung-Hun Lee, Alexa Franke,

Hepatology

1998

170

Characterization of three new imatinib-responsive fusion genes in chronic myeloproliferative disorders generated by disruption of the platelet-derived growth factor receptor   gene

Christoph Walz, Georgia Metzgeroth, Claudia Haferlach,

Haematologica

2007

89

Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV

Manuel Barreto Miranda, Michael Lauseker, M-P Kraus,

Leukemia

2016

87

HCV and HGV in B-cell non-Hodgkin's lymphoma

Volker Ellenrieder, H Weidenbach, Norbert Frickhofen,

Journal of Hepatology

1998

85

Response to pentostatin in hairy-cell leukemia refractory to interferon-alpha. The European Organization for Research and Treatment of Cancer Leukemia Cooperative Group.

Anthony D. Ho, J. Thaler, Franco Mandelli,

Journal of Clinical Oncology

1989

69

Imatinib in myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRB in chronic or blast phase

Mohamad Jawhar, Nicole Naumann, Juliana Schwaab,

Annals of Hematology

2017

58

Interferon-alpha antibodies in patients with renal cell carcinoma treated with recombinant interferon-alpha-2A in an adjuvant multicenter trial

Otto Prümmer

Cancer

1993

48

Incidence and in-vivo relevance of anti-interferon antibodies during treatment of low-grade cutaneous T-cell lymphomas with interferon alpha-2a combined with acitretin or PUVA

Gautham Rajan, Benjamin J. Seifer, Otto Prümmer,

Archives of Dermatological Research

1996

48

Roferon (rIFN-α <sub>2a</sub> ) Is More Immunogenic Than Intron A (rIFN-α <sub>2b</sub> ) in Patients with Chronic Myelogenous Leukemia

Peter von Wussow, R. Hehlmann, T. Hochhaus,

Journal of Interferon Research

1994

38

Circulating tumor necrosis factor alpha (TNF), soluble TNF receptors, and interleukin-6 in human subacute bacterial endocarditis

Winfried V. Kern, Andreas K. Engel, S Schieffer,

Infection and Immunity

1993

37

Page 1